An Alberta lady in her 50s has died after receiving the AstraZeneca COVID-19 vaccine, based on the province’s chief medical officer of well being.
In a information launch issued Tuesday night time, Dr. Deena Hinshaw stated the fatality was confirmed to be linked to “vaccine-induced immune thrombotic thrombocytopenia (VITT).”
Hinshaw stated for affected person confidentiality causes, she wouldn’t present extra case info.
“Whereas any loss of life is tragic, you will need to do not forget that the dangers of dying or struggling different extreme outcomes from COVID-19 stay far higher than the chance following AstraZeneca vaccine,” she stated.
“The Alberta case marks the second VITT case and solely loss of life associated to VITT out of greater than 253,000 doses of AstraZeneca or CoviSHIELD/AstraZeneca which have been administered in Alberta thus far.”
Hinshaw famous that the worldwide frequency of VITT has been estimated at roughly one case in 100,000 to 250,000 doses of the AstraZeneca vaccine.
Enormous Chinese language rocket core falling ‘uncontrolled’ again to Earth
B.C. couple accused of leaping COVID-19 vaccine queue in Yukon again in court docket Could 18
“As compared, Albertans 50 to 59 who’re identified with COVID-19 are 350 instances extra more likely to die from that an infection than to expertise VITT after an AstraZeneca vaccine. They’re additionally a minimum of 1,500 instances extra more likely to be hospitalized from COVID-19 than experiencing VITT after getting AstraZeneca.”
READ MORE: Blood clot dangers: Evaluating COVID-19 vaccines with widespread medicines, journey and smoking
Final month, Canada reported its first case of a uncommon blood clot in a Quebec lady who had obtained the AstraZeneca COVID-19 vaccine.
Watch under: Some World Information movies in regards to the AstraZeneca COVID-19 vaccine.
View hyperlink »
© 2021 World Information, a division of Corus Leisure Inc.